Changes of Metabolic Phenotype of Cardiac Progenitor Cells During Differentiation: Neutral Effect of Stimulation of AMP-Activated Protein Kinase

Stem Cells Dev. 2019 Nov 15;28(22):1498-1513. doi: 10.1089/scd.2019.0129. Epub 2019 Oct 22.

Abstract

Cardiac progenitor cells (CPCs) in the adult mammalian heart, as well as exogenous CPCs injected at the border zone of infarcted tissue, display very low differentiation rate into cardiac myocytes and marginal repair capacity in the injured heart. Emerging evidence supports an obligatory metabolic shift from glycolysis to oxidative phosphorylation (OXPHOS) during stem cells differentiation, suggesting that pharmacological modulation of metabolism may improve CPC differentiation and, potentially, healing properties. In this study, we investigated the metabolic transition underlying CPC differentiation toward cardiac myocytes. In addition, we tested whether activators of adenosine monophosphate-activated protein kinase (AMPK), known to promote mitochondrial biogenesis in other cell types would also improve CPC differentiation. Stem cell antigen 1 (Sca1+) CPCs were isolated from adult mouse hearts and their phenotype compared with more mature neonatal rat cardiac myocytes (NRCMs). Under normoxia, glucose consumption and lactate release were significantly higher in CPCs than in NRCMs. Both parameters were increased in hypoxia together with increased abundance of Glut1 (glucose transporter), of the monocarboxylic transporter Mct4 (lactate efflux mediator) and of Pfkfb3 (key regulator of glycolytic rate). CPC proliferation was critically dependent on glucose and glutamine availability in the media. Oxygen consumption analysis indicates that, compared with NRCMs, CPCs exhibited lower basal and maximal respirations with lower Tomm20 protein expression and mitochondrial DNA content. This CPC metabolic phenotype profoundly changed upon in vitro differentiation, with a decrease of glucose consumption and lactate release together with increased abundance of Tnnt2, Pgc-1α, Tomm20, and mitochondrial DNA content. Proliferative CPCs express both alpha1 and -2 catalytic subunits of AMPK that is activated by A769662. However, A769662 or resveratrol (an activator of Pgc-1α and AMPK) did not promote either mitochondrial biogenesis or CPC maturation during their differentiation. We conclude that although CPC differentiation is accompanied with an increase of mitochondrial oxidative metabolism, this is not potentiated by activation of AMPK in these cells.

Keywords: cardiac progenitors; differentiation; metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinase Kinases
  • Animals
  • Ataxin-1 / genetics
  • Biphenyl Compounds
  • Cell Differentiation / drug effects*
  • Cell Proliferation / drug effects
  • Gene Expression Regulation, Developmental / drug effects
  • Glucose / metabolism
  • Glucose Transporter Type 1 / genetics
  • Glutamine / metabolism
  • Glycolysis / drug effects
  • Heart Injuries / genetics
  • Heart Injuries / metabolism*
  • Heart Injuries / pathology
  • Heart Injuries / therapy
  • Humans
  • Mice
  • Mitochondria / drug effects
  • Mitochondria / genetics
  • Monocarboxylic Acid Transporters / genetics
  • Muscle Proteins / genetics
  • Myocardial Infarction / genetics
  • Myocardial Infarction / metabolism*
  • Myocardial Infarction / pathology
  • Myocardial Infarction / therapy
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism
  • Oxidative Phosphorylation / drug effects
  • Phosphofructokinase-2 / genetics
  • Protein Kinases / genetics*
  • Pyrones / pharmacology
  • Rats
  • Resveratrol / pharmacology
  • Thiophenes / pharmacology

Substances

  • Ataxin-1
  • Atxn1 protein, mouse
  • Biphenyl Compounds
  • Glucose Transporter Type 1
  • Monocarboxylic Acid Transporters
  • Muscle Proteins
  • Pyrones
  • Slc16a4 protein, mouse
  • Slc2a1 protein, mouse
  • Thiophenes
  • Glutamine
  • Protein Kinases
  • PFKFB3 protein, mouse
  • Phosphofructokinase-2
  • AMP-Activated Protein Kinase Kinases
  • Glucose
  • 4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrile
  • Resveratrol